Diamond Biofund Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Other Revenue	-1,697	-2,229	-2,440	1,016	3,064	6,501
Revenue	-1,697	-2,229	-2,440	1,016	3,064	6,501
Revenue Growth (YoY)	-	-	-	-66.85%	-52.88%	-
Gross Profit	-1,697	-2,229	-2,440	1,016	3,064	6,501
Selling, General & Admin	114.59	142.07	148.18	101.92	64.27	404.44
Amortization of Goodwill & Intangibles	0.54	0.41	0.51	0.31	0.11	-
Operating Expenses	143.53	170.65	158.03	113.39	76.13	404.44
Operating Income	-1,841	-2,399	-2,598	902.24	2,988	6,097
Interest Expense	-3.3	-3.77	-0.81	-0.25	-0.55	-0.66
Interest & Investment Income	46.65	15.15	16.24	0.86	0.12	-
Currency Exchange Gain (Loss)	-	-	-	-	-	-4.88
Other Non Operating Income (Expenses)	-5.56	-8.35	-1.7	-21.74	-26.56	-
Pretax Income	-1,803	-2,396	-2,584	881.12	2,961	6,091
Income Tax Expense	122.55	121.63	-0.41	83.34	108.98	1.84
Net Income	-1,926	-2,518	-2,583	797.78	2,852	6,090
Net Income to Common	-1,926	-2,518	-2,583	797.78	2,852	6,090
Net Income Growth	-	-	-	-72.02%	-53.17%	-
Shares Outstanding (Basic)	852	850	779	749	804	674
Shares Outstanding (Diluted)	852	850	779	770	809	685
Shares Change (YoY)	0.16%	9.19%	1.21%	-4.90%	18.16%	1.55%
EPS (Basic)	-2.26	-2.96	-3.32	1.06	3.55	9.03
EPS (Diluted)	-2.26	-2.96	-3.32	1.04	3.52	8.89
EPS Growth	-	-	-	-70.45%	-60.43%	-
Free Cash Flow	3,008	1,125	-2,587	471.63	-300.42	-290.33
Free Cash Flow Per Share	3.53	1.32	-3.32	0.61	-0.37	-0.42
Dividend Per Share	-	-	-	0.170	0.200	0.200
Dividend Growth	-	-	-	-15.33%	-	-
Gross Margin	-	-	-	100.00%	100.00%	100.00%
Operating Margin	-	-	-	88.84%	97.52%	93.78%
Profit Margin	-	-	-	78.55%	93.08%	93.67%
Free Cash Flow Margin	-	-	-	46.44%	-9.81%	-4.47%
EBITDA	-1,833	-2,393	-2,597	903.57	2,990	6,099
EBITDA Margin	-	-	-	88.97%	97.59%	93.82%
D&A For EBITDA	7.46	5.95	1	1.33	2.31	2.43
EBIT	-1,841	-2,399	-2,598	902.24	2,988	6,097
EBIT Margin	-	-	-	88.84%	97.52%	93.78%
Effective Tax Rate	-	-	-	9.46%	3.68%	0.03%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.